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Abstract
Bacterial vaginosis (BV) is a dysbiosis of the vaginal flora characterized by a shift from a Lactobacillus-dominant environment
to a polymicrobial mixture including Actinobacteria and Gram-negative bacilli. BV is a common vaginal condition in women
and is associated with increased risk of sexually transmitted infection and adverse pregnancy outcomes such as preterm
birth. Gardnerella vaginalis is one of the most frequently isolated bacterial species in BV. However, there has been much
debate in the literature concerning the contribution of G. vaginalis to the etiology of BV, since it is also present in a
significant proportion of healthy women. Here we present a new murine vaginal infection model with a clinical isolate of G.
vaginalis. Our data demonstrate that this model displays key features used clinically to diagnose BV, including the presence
of sialidase activity and exfoliated epithelial cells with adherent bacteria (reminiscent of clue cells). G. vaginalis was capable
of ascending uterine infection, which correlated with the degree of vaginal infection and level of vaginal sialidase activity.
The host response to G. vaginalis infection was characterized by robust vaginal epithelial cell exfoliation in the absence of
histological inflammation. Our analyses of clinical specimens from women with BV revealed a measureable epithelial
exfoliation response compared to women with normal flora, a phenotype that, to our knowledge, is measured here for the
first time. The results of this study demonstrate that G. vaginalis is sufficient to cause BV phenotypes and suggest that this
organism may contribute to BV etiology and associated complications. This is the first time vaginal infection by a BV
associated bacterium in an animal has been shown to parallel the human disease with regard to clinical diagnostic features.
Future studies with this model should facilitate investigation of important questions regarding BV etiology, pathogenesis
and associated complications.
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Introduction
One in three women in the U.S. have bacterial vaginosis (BV)
[1], a microbial imbalance of the vaginal flora characterized by the
absence of normally dominant lactobacilli and overgrowth of
complex communities dominated by Gram-negative bacteria and
Actinobacteria [2,3]. BV can be asymptomatic, maybe even part of a
spectrum of ‘normal’ from the patient perspective, but often
displays characteristic clinical features, including ‘‘thinning’’ of
vaginal fluid secretions, increased pH (.4.5), a fishy odor upon
potassium hydroxide treatment, and the presence of clue cells
(epithelial cells studded with bacteria) in wet mounts. An
additional defining feature of BV is the presence of vaginal
sialidase [4–9], an enzyme that cleaves terminal sialic acid residues
from complex glycans, which are abundant on host cell surfaces
and secreted mucus proteins [10–12]. Women with BV are at
increased risk of pelvic inflammatory disease, infections following
surgery or other routine gynecologic procedures, sexually trans-
mitted infections including HIV, and serious pregnancy compli-
cations such as intrauterine infection and preterm birth [13–22].
Unlike most common infectious diseases, BV appears to be
polymicrobial in nature. Recent genomic studies have illustrated
the complexity and heterogeneity of BV, which can vary in
bacterial composition from day to day and from one individual to
another [2,3,23–27]. Although more than a dozen bacterial
species have been associated with BV, the potential causal
contributions of each to the biochemical, cellular, and clinical
features of BV remain elusive. Gardnerella vaginalis was the first
bacterium implicated in the pathogenesis of BV and continues to
be associated with the disease [28]. However, there has been much
debate in the literature concerning the contribution of G. vaginalis
to the development and pathogenesis of BV. G. vaginalis can be
isolated/detected from asymptomatic women that do not meet the
criteria for BV diagnosis at the time of detection [2,27,29–31],
causing some to question its potential role in BV. However,
consistent with the notion of G. vaginalis as a potential pathogen,
strains identified as G. vaginalis have been isolated from invasive
perinatal infections [32–34]. Moreover, several investigations have
described the pathogenic potential of some G. vaginalis isolates in
cell adhesion and entry, cytolytic toxin production, biofilm
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formation, and other phenotypes that may reflect virulence
[26,35–37].
One important diagnostic feature of BV is the presence of clue
cells, which are thought to be exfoliated epithelial cells coated with
bacteria. G. vaginalis, among other BV-associated bacteria, has
been shown to interact with vaginal epithelial cells in culture
[37,38], and clinical studies have shown that vaginal specimens
from women with BV have adhered bacteria on their surfaces
[36,39–42]. However, experimental investigation of the potential
role of Gardnerella vaginalis in generating clue cells in vivo requires an
animal model with features of human BV.
Upon infectious challenge, epithelial cells within the urinary and
genital tracts can undergo a process termed exfoliation, in which
superficial cells appear to be actively shed from the epithelial
surface. In some cases, this is beneficial to the host, flushing
potential pathogens from the mucosa [43,44], while in other cases,
potential pathogens can take advantage of their access to
underlying mucosal tissue [45,46]. Despite much speculation in
the medical literature regarding the potential causes of epithelial
exfoliation in BV, including enzymes such as sialidase and
prolidase or the combination of amines and organic acids
produced by anaerobes [37,47–50], the degree of vaginal epithelial
shedding among women with BV or normal flora does not appear
to have been directly measured or reported in the clinical
literature. Distinguishing whether epithelial exfoliation is actively
induced in BV is necessary for establishing the pathophysiology of
the disease and may be important for understanding why women
with BV are at increased risk of secondary urogenital and
intrauterine infections.
Defining a role for G. vaginalis (or other associated bacteria) in
BV pathogenesis has been hampered by the absence of robust
small animal models that displays phenotypes seen in human BV.
Here we describe the development of a new murine model of G.
vaginalis vaginal infection. This model displays several key features
of BV, including presence of vaginal sialidase activity, and the
presence of epithelial cells with attached bacteria (reminiscent of
clue cells). Additionally, we provide the first quantitative evalua-
tion of vaginal epithelial exfoliation in BV, demonstrating
increased shedding of epithelial cells in both G. vaginalis infected
mice and in clinical specimens from women with BV compared to
mock-infected mice or women with normal flora respectively. This
epithelial response is contrasted by an absence of inflammatory
cell infiltrate, consistent with the lack of vaginal inflammation
found in human BV throughout the literature [51–53]. The results
from this murine model suggest that G. vaginalis alone is sufficient
to yield BV phenotypes and provide further justification for
considering G. vaginalis as a contributor to the causes and
complications associated with BV.
Results
Murine Vaginal and Ascending Uterine Infection by G.
vaginalis Occurs in the Absence of an Overt Inflammatory
Infiltrate
To establish a G. vaginalis murine vaginal infection model, we
used a sialidase-positive G. vaginalis strain (JCP8151B), a clinical
isolate from a woman with BV. From our initial experiments we
found that the majority of b-estradiol-treated C57/Bl6 mice
contained vaginal flora producing large, mucoid colonies on
Gardnerella semi-selective media that occluded the smaller G.
vaginalis colonies. These ‘contaminating’ vaginal flora colonies
were resistant to the addition of a combination of sulfamethox-
azole, trimethoprim sulfate, gentamicin and perfloxacin to
selection plates. Previous vaginal models of G. vaginalis did not
acknowledge the presence of endogenous flora or describe
methods by which G. vaginalis was distinguished and measured
[54,55]. We performed sequencing of genes encoding 16S rRNA
from isolated colonies of the murine vaginal flora and identified
several isolates to be species of Enterococcus (faecalis and gallinarum).
To circumvent this issue and enable accurate determination of G.
vaginalis titers in the murine reproductive tract, we isolated a
spontaneous streptomycin resistant (SmR) mutant of JCP8151B.
We confirmed that the SmR isolate contained the canonical
mutation in the Rpsl gene (K43N) and displayed logarithmic
growth rate and sialidase activity indistinguishable from the parent
strain (data not shown). Using this new JCP8151B-SmR strain, we
inoculated G. vaginalis vaginally into C57/Bl6 mice and deter-
mined CFU levels in vaginal washes and vaginal homogenates at
24 and 72 hours post infection (hpi) (Fig. 1A–B). Colonies
presumed to be G. vaginalis due to growth on streptomycin-
containing plates were also confirmed by PCR using primers
reported to be specific for G. vaginalis [56] (data not shown).
BV has been characterized clinically as a microbial condition
that most often lacks obvious signs of inflammation in vaginal
tissue [57]. To determine the extent of histological inflammation
(edema, neutrophil infiltrate) in our murine model, we performed
hematoxylin and eosin (H&E) staining on vaginal tissues collected
at 24 and 72 hpi. Similar to clinical observations of BV, G. vaginalis
infection did not result in marked tissue inflammation, edema, or
polymorphonuclear (PMN) cell infiltrate (Fig. 1C). The mean
CFU levels in both vaginal washes and homogenates decreased
significantly from 24 hpi to 72 hpi (Fig. 1A–B), suggesting
clearance of the bacteria is occurring by PMN-independent
mechanisms.
There was a strong positive correlation between CFU deter-
mined from vaginal washes and vaginal homogenates (Fig. 2A).
Additional experiments determined that G. vaginalis could persist in
the murine vagina of ,50% of mice for as long as 8 days post
infection (data not shown). G. vaginalis was also found at low levels
(mean 69.5 CFU/g) in the uterine horns of 55% and 45% of mice
at 24 and 72 hpi, respectively. As might be expected, animals with
higher titers of vaginal bacteria were more likely to exhibit
ascending infections of the uterine horns (Fig. 2B–C).
G. vaginalis Leads to Vaginal Sialidase Activity in vivo
A hallmark feature of bacterial vaginosis is the presence of high
levels of sialidase activity in vaginal fluid compared to specimens
from women with normal flora. Our JCP8151B-SmR4 isolate
produces robust sialidase activity in culture. To determine whether
JCP8151B-SmR4 expresses sialidase activity during vaginal
infection, we performed sialidase activity assays on vaginal washes
collected above. Sialidase activity was present in washes from 67%
of G. vaginalis infected mice at 24 hpi, while the majority (86%) of
mock-infected mice contained no detectable sialidase activity
(Fig. 3A). Isolation of vaginal bacteria from the few mock-infected
animals with vaginal sialidase activity demonstrated that these
mice were colonized with sialidase-positive Eubacteria consortium or
Enterococcus spp. (data not shown). The level of sialidase activity
present in washes of infected animals correlated positively with G.
vaginalis CFU levels in vaginal washes and homogenized vaginal
tissue, strongly suggesting that the observed sialidase activity in
infected animals is in fact produced by G. vaginalis (Fig. 3B and
C). Together these results strongly suggest that G. vaginalis
expresses sialidase in the murine vagina and for the first time
establish a prominent biochemical feature of BV in a murine
infection model.
A greater percentage of mice displaying vaginal sialidase activity
also had G. vaginalis in their uterine horns than those mice that
Mouse Vaginal Model of G. vaginalis
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Figure 1. Vaginal infection by G. vaginalis results in minimal histological inflammation. G. vaginalis JCP8151B-SmR4 titers were determined
by enumerating colony forming units (CFU) in vaginal washes (A) and tissue homogenates (B) at 24 and 72 hpi. For samples containing no colonies,
the limit of detection for each was determined and is displayed instead of a value of 0. Results are meta data from 2 independent experiments, each
with 10 mice/infection group. (C) Histological inflammation was assessed by hematoxylin-eosin (H&E) staining of formalin-fixed, paraffin-embedded
vaginal tissue sections.
doi:10.1371/journal.pone.0059539.g001
Mouse Vaginal Model of G. vaginalis
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were sialidase negative (Fig. 3D). These data are consistent with
the observation that higher vaginal titers increase the propensity
for ascending infection.
G. vaginalis Interacts with Murine Vaginal Epithelial Cells
in vitro and in vivo
Another feature of BV, and a component of the Amsel criteria
for BV diagnosis, is the presence of epithelial cells with adherent
bacteria, termed clue cells. G. vaginalis has been shown to interact
with cultured human vaginal epithelial cells and experiments using
vaginal biopsy [42] and vaginal fluid [58] samples suggests that
bacteria may form an adherent biofilm on epithelial cells in the
human vagina. Vaginal washes from G. vaginalis infected mice
often contained clumps of epithelial cells with apparent attached
bacteria (Fig. 4A, panel b, arrowheads).
Additionally, abundant hematoxylin-rich puncta, indicative of
adherent bacteria, were also apparent in some samples upon H&E
staining of vaginal sections (Fig. 4A, panel d). These results
suggested that G. vaginalis may interact with murine vaginal
epithelial cells; however, we could not definitively distinguish G.
vaginalis from murine vaginal flora using histology. Previously used
antibodies for immunofluorescence [36] were unavailable. There-
fore, to provide further confidence that G. vaginalis could interact
with murine vaginal epithelial cells we performed infection assays
with fluorescently labeled G. vaginalis. First we assessed adherence
ex vivo using epithelial cells present in vaginal washes from
uninfected, b-estradiol treated mice. Epithelial cells were washed
extensively to remove endogenous flora, then infected with
fluorescently labeled G. vaginalis and visualized by fluorescent
confocal microscopy. G. vaginalis adhered to mouse vaginal
epithelial cells, appearing as distinct fluorescent puncta or
biofilm-like collections decorating the epithelial cell surface
(Fig. 4B). Similar puncta were not observed on epithelial cells
inoculated with a ‘‘mock’’ preparation (containing the fluorescent
label but no bacteria), demonstrating that this pattern of
fluorescence was specific to G. vaginalis and not an artifact of the
introduction of the RBITC label. Next we determined whether we
could observe such interactions during in vivo infection. Following
vaginal inoculation with fluorescently labeled G. vaginalis, similar
fluorescent puncta were detected on epithelial cells in vaginal
washes from infected mice at 4 hpi. Together, these results
demonstrate that G. vaginalis adheres to murine vaginal epithelial
cells, similar to what has been seen for human-derived cultured
epithelial cells [37,38].
G. vaginalis Infection Results in Robust Epithelial
Exfoliation
While G. vaginalis did not elicit a robust inflammatory response,
we observed that the epithelial surfaces of G. vaginalis infected mice
displayed evidence of epithelial cell exfoliation (see Fig. 1C). To
gain a semi-quantitative perspective of this phenotype, we scored
the degree of histological exfoliation in slides that were blinded to
the observer, with 0 being none and 3 being very robust (see
Fig. 5B for representative images). Vaginal sections from G.
vaginalis-infected mice had significantly higher exfoliation scores
compared to mock-infected controls (Fig. 5A). Additionally, G.
vaginalis infection resulted in increased thickness of the transitional
epithelium (Fig. 5C), which correlated positively with exfoliation
score (Fig. 5D), suggesting that there may be increased epithelial
proliferation in response to the surface exfoliation. Inoculation of
heat-killed G. vaginalis did not result in a significant increase in
either epithelial exfoliation score or thickness (Fig. 5A&C),
demonstrating that live bacteria are required to induce this
response.
As an additional assessment of this apparent exfoliation
response, we examined vaginal washes by wet mount light
microscopy. Consistent with our observations of H&E stained
vaginal sections, vaginal washes from both mock and G. vaginalis
infected mice contained predominantly epithelial cells with very
limited, if any, leukocytes (representative images shown in
Fig. 6A). We enumerated epithelial cells, again in a blinded
manner, and found that G. vaginalis infected mice had significantly
higher numbers of epithelial cells in vaginal washes compared to
mock-infected animals or those exposed to heat-killed G. vaginalis
(Fig. 6B). Finally, the degree of epithelial exfoliation in mice
infected with G. vaginalis correlated positively with both vaginal
wash CFU and sialidase activity (Fig. 6C–D), consistent with this
response being relative to infectious burden. Together these results
show that G. vaginalis JCP8151B induces a robust vaginal epithelial
exfoliation response in a murine vaginal infection model.
Figure 2. G. vaginalis titers in vaginal washes reflect titers in vaginal tissue and correlate directly with titers of G. vaginalis in uterine
horns. Vaginal wash and tissue titers determined as in Fig. 1 were plotted and analyzed using GraphPadH Prism 5.0. ***P,0.001; *P,0.05. Results are
meta data from 2 independent experiments, each with 10 mice/infection group.
doi:10.1371/journal.pone.0059539.g002
Mouse Vaginal Model of G. vaginalis
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Epithelial Exfoliation as a Clinical Feature of Bacterial
Vaginosis
Pathogen induction and blockade of host epithelial exfoliation
responses has been described in other murine urogenital infection
models. For example, uropathogenic E. coli (UPEC) induces
exfoliation of superficial umbrella cells lining the bladder, which is
thought to be consistent with the progression of acute UTI in
humans [59–62]. However, N. gonorrhea has been shown to block
vaginal epithelial exfoliation through interactions with human
specific receptors (carcinoembryonic antigen-related cell adhesion
molecules, CEACAMs) [63,64]. Although the presence of
epithelial clue cells is a well-established clinical feature of BV,
we found no examples in the literature measuring whether the
relative number of epithelial cells in clinical specimens is increased
in women with BV compared to those with normal flora. To
determine whether the increased number of epithelial cells seen in
our murine model is a verifiable feature of human BV, we
performed microscopic enumeration of vaginal epithelial cells on
slides prepared from human vaginal swabs from women with (+)
and without (2) BV as defined by Nugent score (7–10 and 0–3
respectively) (Fig. 7). Consistent with the murine model,
significantly higher levels of epithelial cells were observed on
slides prepared from specimens of women with BV compared to
women with normal flora (Fig. 7). These results strongly suggest
that an epithelial exfoliation host response occurs in the clinical
setting of BV.
Discussion
Bacterial vaginosis (BV) is a common vaginal condition in
women [1,13] and is associated with increased risk of sexually
Figure 3. Vaginal sialidase activity correlates with G. vaginalis vaginal infection and is associated with ascending uterine horn
infection. (A) Sialidase enzymatic activity was determined in vaginal washes from mock and G. vaginalis infected mice at 24 and 72 hpi and
statistical significance determined by the Mann-Whitney test. The dotted line represents the cutoff value used to distinguish sialidase (+) from
sialidase (2) vaginal washes for performing Fisher’s exact test, shown in the box above. Results are meta data from 4 independent experiments
(24 hpi-mock n= 44, G. vaginalis n=70; 72 hp-mock n= 29, G. vaginalis n= 40). The sialidase activity value from each G. vaginalis-infected mouse was
plotted against G. vaginalis CFU in the corresponding vaginal wash (B) or tissue homogenate (C) and Spearman correlations were determined.
***P,0.0001; **P,0.005. (D) Fisher’s exact test to determine whether ascending uterine horn infection by G. vaginalis was contingent upon the
presence of vaginal sialidase activity. Results shown represent combined data from both 24 and 72 hpi, though each time point was significant when
analyzed individually.
doi:10.1371/journal.pone.0059539.g003
Mouse Vaginal Model of G. vaginalis
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transmitted infection and adverse pregnancy outcomes, including
preterm birth [13–22]. Despite its prevalence, the etiolog(ies) of
BV symptoms and complications are poorly understood. There is
an obvious and dramatic shift in the overall vaginal flora from a
Lactobacillus-dominant state to one overrun by high titers of Gram-
negative anaerobes and Actinobacteria. A handful of bacteria have
come to be known as BV-associated bacteria, including G. vaginalis.
However the contribution of these BV-associated bacteria to the
overall disease state is largely undefined. A significant contributing
factor to this dearth of understanding is the absence of relevant
small animal models.
We found a few recent reports in the literature describing
murine vaginal inoculation with G. vaginalis. Two of these papers
investigated the effects of Lactobacillus probiotic strains on G.
vaginalis colonization in an outbred mouse strain [54,55]. However,
the methods of isolation and enumeration of G. vaginalis vaginal
titers in these papers were only loosely described. For example, G.
vaginalis recovered from infected mice were reported as a
percentage of the no probiotic control group rather than an
absolute enumeration of recovered colony forming units, ham-
pering assessment of the overall bacterial load. Although possibly
explained by a difference in mouse strain used or conditions of the
housing or breeding facility, there was also no reference to the
incidence of contaminating vaginal flora, which we found
invariably present in our mouse model. In addition to these two
studies, there is one report of vaginal G. vaginalis infection in
gnotobiotic mice [65], which naturally circumvents the issue of
contaminating flora.
Here we describe a murine vaginal infection model with G.
vaginalis that is, to our knowledge, the first to recapitulate key BV
phenotypes. Technically speaking, this model is rather straight-
forward and very similar to infection models utilized for other
vaginal pathogens. However, the model described here is
distinguishable by the fact that previous studies of G. vaginalis
infection in mice did not investigate BV-related phenotypes in vivo.
Furthermore, we took multiple measures to ensure accuracy of our
G. vaginalis titer enumeration, including 1) generating a strepto-
mycin-resistant (SmR) isolate, and 2) confirming by PCR that
bacteria re-isolated from mouse vaginal washes were G. vaginalis.
Vaginal inoculation with G. vaginalis was sufficient to yield 1)
Figure 4. G. vaginalis adheres to murine vaginal epithelial cells in vitro and in vivo. (A) Phase contrast light microscopy of vaginal wash wet
mounts (panels a and b) and H&E staining of vaginal tissue sections (panels c and d) from mock (a and c) and G. vaginalis (b and d) infected mice.
Arrows in panel b and dark purple puncta in panel d illustrate potentially adherent bacteria in G. vaginalis-infected samples. (B) Fluorescent confocal
microscopy images (with corresponding bright-field images) of vaginal epithelial cells either mock (top) or RBITC labeled G. vaginalis (bottom)
infected in vitro for 3 h at 37uC. (C) Fluorescent confocal microscopy images of vaginal washes from mock or RBITC labeled G. vaginalis infected mice,
collected at 4 hpi.
doi:10.1371/journal.pone.0059539.g004
Mouse Vaginal Model of G. vaginalis
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Figure 5. G. vaginalis induces a robust histological epithelial exfoliation and proliferation response. (A) Histological exfoliation scoring.
H&E stained, formalin-fixed, paraffin-embedded vaginal tissue sections from the 24 hpi time point were assessed for evidence of epithelial exfoliation
(eosin-rich layers of epithelial cells superficial to the transitional epithelium) and assigned a numerical value from 0–3, with 0 = none and 3= very
robust. The Kruskal-Wallis test was used to for statistical evaluation of differences between groups (P = 0.0161). For pairwise comparisons, post-hoc
testing was performed using the Mann-Whitney U-test, with significance indicated in the figure. *P,0.05. Upon conservative correction for multiple
comparisons with Bonferroni-Holm, the non-parametric tests remain significant. (B) Representative images of epithelial scoring, with white, capped
lines representing the measured thickness of the transitional epithelial layer shown in (C). (C) Using the same samples from (A), average thickness of
the transitional epithelium was determined from five measurements per sample using StreamStartH software. Results in each graph are meta-data
from 4 independent experiments (mock n= 36, G. vaginalis n= 25, heat-killed (HK) G. vaginalis n= 10). The data passed the D’Agostino & Perason
omnibus normality test. Therefore, a one-way ANOVA was used detected significant differences between groups (P = 0.0004), followed by post-hoc
pairwise comparisons using the unpaired t-test. **P,0.01; ***P,0.001. Again, differences remained significant with the conservative Bonferroni
correction. (D) Transitional epithelium thickness values from (C) were plotted against exfoliation scores from (A) and Spearman correlation was
determined. ***P,0.001.
doi:10.1371/journal.pone.0059539.g005
Mouse Vaginal Model of G. vaginalis
PLOS ONE | www.plosone.org 7 March 2013 | Volume 8 | Issue 3 | e59539
vaginal sialidase activity; 2) epithelial cells with adherent bacteria
(reminiscent of clue cells); 3) epithelial exfoliation in the absence of
an inflammatory infiltrate. Together, results from this model
demonstrate that G. vaginalis likely plays a role in generating these
clinical features observed in humans and each is discussed in
further detail below.
Sialidase Activity
Sialidase activity is rarely detected in women with normal flora
[19,66,67]. In pregnant women, sialidase activity has also been
independently correlated with increased risk of chorioamnionitis
and PTB [19,68]. Production of sialidase by isolated BV-
associated bacteria grown in culture strongly suggests that BV-
associated sialidases are bacterial in origin [69,70]. Bacterial
sialidases have been characterized as virulence factors in bacterial
infections of various mucosal sites [71]. Our previous in vitro
studies have highlighted the potential role of G. vaginalis sialidase in
the deglycosylation and degradation of host glycoproteins [72]. In
our murine model, the level of sialidase activity correlates with
vaginal G. vaginalis titers and sialidase positive mice are more likely
to develop uterine horn infection. These data suggest that higher
vaginal titers are more likely to result in ascending infection.
Although further studies are required, these results may also
suggest potential role for sialidase in the mechanisms facilitating
ascending infection. Consistent with this idea, sialidase activity
levels in pregnant women correlated directly with increased risk of
chorioamnionitis and preterm birth [7,68].
G. vaginalis and the Formation of Clue Cells
It has long been established that BV bacteria interact with
epithelial cells. In fact, the presence of exfoliated clue cells is a
qualitative diagnostic feature of the disease [73,74]. It has
previously been suggested that G. vaginalis may be responsible for
clue cell formation, since it was detected on the surface of
exfoliated vaginal epithelial cells more frequently and at higher
levels than the BV-associated anaerobes Mobiluncus, Bacteroides, and
Fusobacterium [39]. A more recent high-resolution phylogenetic
study examining correlations between different species of BV
bacteria and clinical features revealed that G. vaginalis is positively
associated with the presence of clue cells [75]. G. vaginalis has also
Figure 6. G. vaginalis-induced exfoliation is evident in vaginal washes and correlates with vaginal titers and sialidase activity. (A)
Representative images of phase contrast light microscopy fields of vaginal wash wet mounts from mock, G. vaginalis and HK G. vaginalis infection
groups, as indicated, used in (B) to enumerate epithelial cells. (B) The average numbers of epithelial cells per field of view were calculated from 5
images per sample. Results are meta-data from 4 independent experiments (mock n= 51, G. vaginalis n= 74, HK G. vaginalis n=19). The Kruskal-Wallis
test was used to for statistical evaluation of differences between groups (P = 0.0065). The Mann-Whitney U-test was used for post-hoc pairwise
comparisons, with significance indicated in the figure. **P,0.01; *P,0.05. Differences remained significant with the conservative Bonferroni-Holm
correction for multiple comparisons. (C) and (D) Epithelial counts were plotted against their corresponding vaginal wash CFU (C) or sialidase activities
(D) and Pearson correlations were determined.
doi:10.1371/journal.pone.0059539.g006
Mouse Vaginal Model of G. vaginalis
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been shown to interact with a vaginal epithelial cell line [36] and
epithelial cells present in human clinical samples [40,76]. We
demonstrated, using fluorescently labeled bacteria, that G. vaginalis
interacts with murine vaginal epithelial cells, forming clue-like cells
in vitro. Labeled G. vaginalis was also detected on the surface of
epithelial cells recovered from vaginal washes of mice following
infection with G. vaginalis. Together these data provide evidence
that our murine model of G. vaginalis infection displays this
important feature of BV and provides an avenue for investigating
clue cell formation in vivo.
G. vaginalis Induces Epithelial Exfoliation in the Absence
of Overt Inflammation
BV is characterized by a heavy overgrowth of Actinobacteria and
Gram-negative anaerobes but a surprising absence of the type of
inflammatory infiltrate seen in other urogenital infections such as
gonococcal infection [77,78] or urinary tract infection [46,79,80].
Epithelial shedding, or exfoliation, appears to be a common
mechanism of protection employed by mucosal surfaces [81,82].
G. vaginalis vaginal infection in mice produced a robust exfoliation
response that correlated directly with vaginal titers and vaginal
sialidase activity.
Consistent with the lack of overt inflammation in women with
BV [83], our histological and wet mount microscopy analyses of
vaginal specimens from mice infected with G. vaginalis displayed no
signs of polymorphonuclear leukocyte (PMN) recruitment. Even
though estradiol treatment suppresses the influx of PMNs that
naturally occurs in mice after ovulation [84], literature evidence
has shown that PMN recruitment to the vagina can still occur
upon infectious challenge in C57/Bl6 mice [85]. Although no
quantitative data was given, Teixeira et al. reported the presence
of ‘inflammatory lesions’ in the vaginas of gnotobiotic mice
infected with G. vaginalis [65]. It is reasonable to suspect that
indigenous microflora in the vagina may contribute to host innate
immune responses, as has been shown in the gut [86,87]. This may
influence inflammatory responses to G. vaginalis in mice lacking
endogenous flora. Further studies are required to provide a better
understanding of the role of G. vaginalis in the apparent suppression
of inflammatory responses that occurs during BV. Recent
biochemical and genomic investigations have revealed that G.
vaginalis isolates can be remarkably diverse [88–91], perhaps
allowing different host responses to various strains of G. vaginalis.
Epithelial Exfoliation as a Measurable Clinical Feature:
Implications for Understanding BV
Epithelial exfoliation has long been discussed in the BV
literature, most often with regard to clue cells. Although there
are countless references to ‘‘increased epithelial exfoliation’’ in BV,
we found no examples of quantitative analysis in a defined
experimental or clinical setting. We present evidence that an
increased vaginal epithelial exfoliation response, a robust feature
of the G. vaginalis animal model described here, is also apparent in
Gram-stained images of vaginal fluids from women with BV
(Nugent 7–10) compared to normal controls (Nugent 0–3). Our
analysis of clinical samples provides the first concrete evidence to
classify an exfoliation response as a BV phenotype.
The modest but significant increase in the number of exfoliated
epithelial cells in women with BV may be a beneficial response if it
removes adherent potential pathogens and when surface epithelial
layers can be replenished. However, excessive exfoliation may
promote access to underlying tissue, which may facilitate the
establishment of BV-associated bacteria and increase the risk of
secondary infection. In fact, BV is known to be associated with
increased risk of certain sexually-transmitted infections (STI)
[18,92,93] and some vaginal pathogens can take advantage of the
exfoliation process to facilitate access to underlying tissue. For
example, T. vaginalis causes contact-dependent cytotoxicity upon
adherence to vaginal epithelial cells, thereby leading to exfoliation
and erosion of the epithelium. It has been suggested that this may
allow trichomonads into extracellular matrix and basement
membrane sites within the vaginal tissue [45]. It is possible that
removal of the outer epithelial cell layer by G. vaginalis provides a
niche for formation of an adherent biofilm, which has been
observed in vaginal biopsies from women diagnosed with BV [42].
Interestingly, BV correlates with T. vaginalis infection, therefore it
is conceivable that exfoliation induced by G. vaginalis and T.
vaginalis could be mutually beneficial and may also impact other
vaginal organisms. Interestingly, some vaginal microbicides have
been shown to have paradoxical effects, actually increasing
susceptibility to HIV and other sexually-transmitted pathogens.
This increased susceptibility was found to be coincident with rapid
exfoliation and re-growth of epithelial cell layers [94]. These
previous findings are consistent with the idea that epithelial
exfoliation in BV may contribute to increased STI risk. Future
studies should examine whether epithelial exfoliation may
contribute to the overall risk of secondary infections associated
with BV.
We found a single reference in the literature that performed
quantitative analysis of vaginal epithelial shedding (by counting
epithelial cells present in vaginal lavage samples). Interestingly, this
study uncovered a link between vaginal epithelial exfoliation and
smoking [95], a behavior that has been shown to be associated
with BV [96]. If exfoliation promotes vaginal colonization by BV
bacteria, it is tempting to speculate that the link between smoking
and BV could be explained, at least in part, by the initiation of
epithelial exfoliation that occurs in smokers. Ultimately, the
downstream ramifications of epithelial exfoliation for the overall
pathophysiology of BV remain to be explored and the new murine
Figure 7. Human clinical samples display evidence of epithelial
exfoliation associated with bacterial vaginosis. Heat-fixed, Gram
stained slides were prepared from fresh human vaginal swabs and
classified as BV (+) or no BV (2) by Nugent scoring (scores 7–10 and 0–3
respectively). The average number of epithelial cells per field of view
was calculated from 3 images per sample. BV (2) n = 28, BV (+) n = 27.
The Mann-Whitney U-test was used for statistical evaluation of
differences between groups. ***P,0.0001.
doi:10.1371/journal.pone.0059539.g007
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model presented here provides a valuable tool for these
investigations.
G. vaginalis as a Pathogen
Since it was first described, there has been vigorous debate in
the literature regarding the role of G. vaginalis in BV. G. vaginalis is
one of the most frequently isolated bacterial species from women
with BV. Consistent with the notion of G. vaginalis as a potential
pathogen, strains identified as G. vaginalis have been isolated from
placenta, amniotic fluid, and blood [32–34]. G. vaginalis has also
been implicated in uterine infections and development of
endometritis [97]. Results from a comparison of epithelial
adhesion, cytotoxicity and biofilm formation between several BV
associated bacteria suggested that G. vaginalis may be more virulent
than other species associated with the disease [37]. The
observation that G. vaginalis produces BV phenotypes in our
murine model, in the absence of other BV-associated bacteria,
emphasizes its likely role in BV etiology. However, the main
controversy appears to lie in the fact that G. vaginalis can also be
detected from women with normal flora [2,27,29–31]. We argue
that the presence of G. vaginalis in healthy individuals does not
constitute a basis for disregarding this bacterium in the causes and
complications of BV. Just as ‘‘healthy’’ people can be asymptom-
atic carriers of such pathogens as Streptococcus pneumoniae [98],
Group A Streptococcus [99,100], Haemophilus influenzae [98] or
Clostridium difficile [101], carrier states may also exist for G. vaginalis.
Indeed, recent genomic and phenotypic studies support the
hypothesis that variations in bacterial strain virulence, titers,
and/or windows of host susceptibility may bring a colonization
state to a state of pathogenesis [38,88,91,102,103].
In summary, our results demonstrate for the first time that G.
vaginalis is sufficient to yield key BV phenotypes in an animal
model. The quantitative experimental methods described here
show that infection with G. vaginalis leads to vaginal sialidase
activity, bacterial adherence to vaginal epithelial cells, and a robust
epithelial exfoliation response that we demonstrate as a relevant
clinical feature of BV in quantitative, controlled experiments.
These data provide strong evidence that G. vaginalis can play an
active role in generating clinical features associated with BV. The
phenotypic parallels to human BV displayed in the murine system
provide a new experimental tool with great potential to expand
our understanding of G. vaginalis-host interactions in the vagina.
Materials and Methods
Ethics Statement
Vaginal swabs were collected as part of the Contraceptive
CHOICE project [104] according to protocols approved by the
Washington University Institutional Review Board (IRB ID#
201108155). Mouse experiments were carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals. The protocol was approved by
the Animal Studies Committee of Washington University School
of Medicine (Protocol Number: 20110149).
Bacterial Strains and Growth Conditions
Gardnerella vaginalis clinical isolate JCP8151B (GenBank
JX860320) was obtained from a vaginal swab from a woman
with BV (based on Nugent score) obtained in accordance with
IRB-approved protocols in collaboration with the Washington
University Contraceptive CHOICE Project (IRB ID#
201108155). The vaginal swab was transported from the clinic
to the lab using Port-A-CulTM pre-reduced anaerobic transport
media tubes (BD). Tubes were brought into a Vinyl anaerobic
airlock chamber (Coy Products) under an atmosphere maintained
at approximately 1% hydrogen and 0 ppm oxygen. Within 24
hours and the swab was used to inoculate ‘‘Gardnerella semi-
selective media,’’ (agar plates with 5% defibrinated sheep blood,
10 mg/L colistin, 10 mg/L nalidixic acid, and 4 mg/L ampho-
tericin B). Plates were pre-incubated in the chamber for at least 16
hours for equilibration to anaerobic conditions and were
incubated anaerobically post-inoculation at 37uC for 24–48 hours.
Translucent pinpoint colonies were isolated, and candidate G.
vaginalis strains were tested by diagnostic PCR using primers
previously reported to be specific for G. vaginalis (forward primer
GGGCGGGCTAGAGTGCA and reverse primer
GAACCCGTGGAATGGGCC) [56]. Additional validation of
the G. vaginalis identity was obtained by sequencing 16S rDNA.
Full details of this strain are being reported in a separate
manuscript.
A spontaneous streptomycin resistant mutant, JCP8151B-SmR
#4, was isolated by plating JCP8151B (concentrated from a 2 day,
25 mL NYC-III culture) on Gardnerella semi-selective media
+1 mg/mL streptomycin and selecting resistant colonies after
incubating anaerobically at 37uC for 72 hours. We confirmed the
streptomycin resistance in this isolate was due to point mutation of
the Rpsl gene (as that reported for other bacteria) by amplifying G.
vaginalis Rpsl with primers rpsL F2 (CATGGTT-
TAAGGTGTGCTG) and rpsL R (GTTAATCAACTGAGC-
CACG) and sequencing using rpsL F2. To confirm that the point
mutation did not result in any apparent growth defects or changes
in sialidase activity, JCP8151B and JCP8151B-SmR #4 were
grown anaerobically overnight in 5 ml NYC-III medium at 37uC,
then diluted to OD600 of 0.1 in 5 mL NYC-III medium. A 25 mL
aliquot of each bacterial suspension was analyzed for sialidase
activity as described below. The remaining bacterial suspension
was incubated anaerobically at 37uC for 24 hr to monitor growth.
Aliquots were removed at 0, 1, 3, 6 and 24 h, serial diluted and
plated on Gardnerella semi-selective media to enumerate colonies.
Results for sialidase activity and growth curves were indistinguish-
able between JCP8151B and JCP8151B-SmR. The JCP8151B-
SmR isolate was used for murine infection model experiments
described below. Control experiments (as dictated in figures and
figure legends) treated a parallel group of mice infected with
JCP8151B-SmR that was heat-killed by incubation of the bacterial
inoculum at 80uC for 10 min.
Murine Vaginal Infection Model
Female C57/Bl6 mice (6–8 weeks) were injected intraperitone-
ally with 0.5 mg b-estradiol in 100 mL filter-sterilized sesame oil
three days prior to and on the day of inoculation. Mice were
anaesthetized with isofluorane and inoculated vaginally with
,56107 CFU G. vaginalis in 20 mL sterile PBS (OD600 = 5.0).
Vaginal washes were collected by flushing vaginas with 50 mL
sterile PBS using a P200 pipet (GeneMate), pipetting up and down
10x, followed by rinsing into an additional 10 mL PBS in a sterile
1.5 mL Eppendorf tube. G. vaginalis titers were determined from
washes by preparing 10-fold serial dilutions in PBS (in the
anaerobic chamber) and spotting 5 mL of each dilution in
quadruplicate onto 1 mg/mL streptomycin selection plates (either
Gardnerella semi-selective media or NYC-III agar). Colonies were
then enumerated and reported as recovered colony forming units
(CFU) per mL of vaginal fluid. Vaginal washes were also analyzed
for sialidase activity and epithelial exfoliation as described below.
Mice were sacrificed at 24 hpi or 72 hpi to harvest vaginas and
uterine horns. One uterine horn and half of the vagina (bisected
longitudinally) from each mouse was homogenized followed by
serial dilution and plating as for vaginal washes. Colonies were
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enumerated and reported as CFU per gram of tissue. The
remaining vaginal tissue and uterine horn from each mouse were
fixed in 10% buffered formalin phosphate at room temperature
followed by paraffin embedding. Histological slide preparation
and H&E staining were performed by the Washington University
School of Medicine Histology Core.
Sialidase Activity Assays
Vaginal wash samples collected as described above (25 mL) were
diluted 1:2 with 100 mM sodium acetate pH 5.5 containing
300 mM 4-methylumbelliferyl-Neu5Ac (50 mL). Substrate hydro-
lysis was monitored using a Tecan M200 plate reader.
G. vaginalis Interaction with Murine Vaginal Epithelial
Cells in vitro and in vivo
G. vaginalis JCP8151B was fluorescently labeled with Rhoda-
mine B isothiocyanate (RBITC; Aldrich 283924). RBITC was
prepared fresh at 0.2 mg/mL in 20 mM HCl and 5 mL of this
stock was added to 500 mL G. vaginalis JCP8151B in sterile PBS
(prepared as described for mouse experiments above). The
bacteria were then incubated anaerobically at 37uC for 30 min,
centrifuged, resuspended in 500 mL NYC-III and allowed to
recover with an additional 30 min, 37uC anaerobic incubation.
Finally, the labeled bacteria were washed twice with PBS and
resuspended in 500 mL PBS for inoculation of epithelial cells, as
described below. For each experiment a ‘‘mock’’ labeled sample,
lacking bacteria, was prepared in parallel.
While G. vaginalis was being labeled, vaginal washes were
collected from b-estradiol-treated mice, as described above.
Washes were pooled and spun at 300 g for 5 min to collect
epithelial cells. Epithelial cells were then washed 3 times with
sterile PBS to remove the majority of endogenous flora and then
distributed in 50 mL aliquots into 1.5 mL eppendorf tubes.
RBITC-labeled G. vaginalis or the ‘‘mock’’ labeled sample (5 mL)
were added to the epithelial cells and the samples were rotated at
37uC for 3 hours. Finally, epithelial cells were washed twice to
remove unassociated bacteria and then visualized on an Olympus
BX61 confocal fluorescent microscope using SlideBook 5.0
software.
For in vivo analyses, G. vaginalis was labeled with RBITC as
described for in vitro experiments and then inoculated vaginally
into b-estradiol-treated mice as described above. An additional
group of mice was inoculated with a ‘‘mock’’-label preparation
containing no bacteria. At 4 hpi, mouse vaginas were washed with
50 mL PBS and epithelial cells were visualized by confocal
fluorescent microscopy as described above.
Analysis of Murine Epithelial Cell Exfoliation
H&E stained mouse vaginal histology sections collected above
were visualized on an Olympus BX61 microscope to assess the
degree of inflammation (24 hpi and 72 hpi time points) and
epithelial exfoliation (24 hpi time point). Images were captured
and epithelial thickness was measured using StreamStartH
software, with averages calculated from 5 measurements per
vaginal section.
For assessment of epithelial exfoliation in mouse vaginal washes,
wet mounts were prepared with 5 mL vaginal wash (from the
24 hpi time point) and visualized by phase contrast microscopy
using an Olympus BX61 microscope. Five representative images
were captured from each specimen (1 per mouse) and epithelial
cells were counted from each image to determine an average.
Clinical Specimen Handling and Analysis of Epithelial
Exfoliation
Vaginal swabs (Starplex) were collected as part of the
Contraceptive CHOICE project [104)] according to protocols
approved by the Washington University Institutional Review
Board (IRB ID# 201108155) and underwent Nugent scoring
using published methods as previously described [72,105]. Gram
stained slides (the same used for Nugent scoring) were analyzed for
epithelial exfoliation by enumerating epithelial cells in three
representative images as described for murine samples above.
Statistical Analysis
GraphPad Prism 5.0 software was used for all statistical analyses
presented. The statistical tests used to analyze each set of data are
indicated in the figure legends.
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